Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (14.286%)
Market Cap: £11.04m
EMR Live PriceLast checked at - London Stock Exchange

Intraday Empresaria Group Share Chart

Form 8.5 (EPT/RI)

17 Jun 2025 09:56

RNS Number : 1780N
Singer Capital Markets Sec Ltd
17 June 2025
ย 

FORM 8.5 (EPT/RI)

ย 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

ย 

1. KEY INFORMATION

ย 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

ย 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

EMPRESARIA GROUP PLC

ย 

(c) Name of the party to the offer with which exempt principal trader is connected:

EMPRESARIA GROUP PLC

ย 

(d) Date dealing undertaken:

16 June 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

ย 

N/A

ย 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

ย 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

ย 

The currency of all prices and other monetary amounts should be stated.

ย 

(a) Purchases and sales

ย 

Class of relevant security

Purchases/ sales

ย 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ย 

ORD 5P

ย 

Sales

ย 

37,128

ย 

28.9p

ย 

28.9p

ย 

(b) Cash-settled derivative transactions

ย 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

ย 

ย 

ย 

(c) Stock-settled derivative transactions (including options)

ย 

(i) Writing, selling, purchasing or varying

ย 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

ย 

(ii) Exercise

ย 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

ย 

ย 

ย 

ย 

ย 

ย 

ย 

(d) Other dealings (including subscribing for new securities)

ย 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

ย 

ย 

ย 

ย 

ย 

ย 

3. OTHER INFORMATION

ย 

(a) Indemnity and other dealing arrangements

ย 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

ย 

None

ย 

ย 

(b) Agreements, arrangements or understandings relating to options or derivatives

ย 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

ย 

None

ย 

ย 

ย 

Date of disclosure:

17 June 2025

Contact name:

Jennifer Bentickย 

Telephone number:

020 7496 3055

ย 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.ย 

ย 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

ย 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
FERUBVWRVSUNARR
Date   Source Headline
12th May 20217:00 amRNSTransaction in Own Shares
11th May 20217:00 amRNSTransaction in Own Shares
6th May 20217:00 amRNSSenior Leadership Appointments
4th May 20217:00 amRNSTransaction in Own Shares
29th Apr 20217:00 amRNSTransaction in Own Shares
28th Apr 20217:00 amRNSTransaction in Own Shares
23rd Apr 20217:00 amRNSTransaction in Own Shares
13th Apr 20217:00 amRNSAnnual Report and Accounts and Notice of AGM
12th Apr 202112:28 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSTransaction in Own Shares
26th Mar 20212:54 pmRNSDirector/PDMR Shareholding
19th Mar 20217:00 amRNSTransaction in Own Shares
18th Mar 20217:00 amRNSFinal Results
2nd Mar 20217:00 amRNSInvestor Meet Company Presentation
22nd Feb 20212:19 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSTrading Update and Notice of Results
22nd Dec 20201:18 pmRNSTransaction in Own Shares & Total Voting Rights
18th Dec 20209:41 amRNSTransaction in Own Shares
2nd Dec 20207:55 amRNSTransaction in Own Shares
2nd Dec 20207:00 amRNSTrading Update
12th Nov 20207:00 amRNSTransaction in Own Shares
5th Nov 20207:00 amRNSTransaction in Own Shares
29th Oct 20201:38 pmRNSHolding(s) in Company
7th Oct 202010:02 amRNSTransaction in Own Shares
6th Oct 20207:00 amRNSTransaction in Own Shares
25th Sep 20202:56 pmRNSTransaction in Own Shares
22nd Sep 20207:00 amRNSTransaction in Own Shares
9th Sep 20205:39 pmRNSTransaction in Own Shares
8th Sep 20203:15 pmRNSDirector / PDMR Shareholding
18th Aug 20207:00 amRNSTransaction in Own Shares
12th Aug 20207:00 amRNSInterim Results
10th Aug 20207:00 amRNSInvestor Meet Company presentation
31st Jul 20207:00 amRNSRevision: Trading Update and Notice of Results
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
1st Jul 20203:36 pmRNSTransaction in Own Shares
30th Jun 202012:40 pmRNSTransaction in Own Shares
25th Jun 20208:54 amRNSTransaction in Own Shares
17th Jun 20205:18 pmRNSShare Buyback Programme
27th May 20201:04 pmRNSDirector/PDMR Shareholding
26th May 20201:23 pmRNSResult of AGM
26th May 20207:00 amRNSTrading update, acq. of non-controlling interest
8th Apr 20207:00 amRNSTrading and COVID-19 Update and Notice of AGM
30th Mar 20204:32 pmRNSAwards pursuant to the Company's LTIP
20th Mar 202012:08 pmRNSDirector/PDMR Shareholding
18th Mar 20201:10 pmRNSDirector Dealing
18th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSChange of Nominated Adviser and Broker
5th Feb 20202:53 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
3rd Dec 201910:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.